Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-09-19

Clinical Trial Update: Magseed Pro(R)/ Sentimag(R) Gen3 [NA]

View source ↗

Summary

The trial update shows that a study evaluating Magseed Pro and Sentimag Gen3 for breast cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Magseed Pro
  • Sentimag Gen3

Snippet

Sponsor: Endomagnetics Ltd. | Conditions: Breast Cancer | NA | Status: RECRUITING